Arca Biopharma reported $4.6M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Amgen USD 653M 94.99B Sep/2026
Arca Biopharma USD 4.6M 4.1M Mar/2026
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 403M 4M Sep/2026
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cipla INR 167.4M 2.9M Sep/2026
Compugen USD 1.84M 485K Jun/2026
CSL USD 215M 111M Dec/2025
Cytokinetics USD 38.48M 3.65M Sep/2026
Daiichi Sankyo JPY 14.13B 10.56B Sep/2026
Gilead Sciences USD 269M 22M Sep/2026
GlaxoSmithKline GBP 219M 98M Sep/2026
Grifols EUR 156.07M 31.46M Sep/2025
Laboratory Of America USD 59.1M 2M Sep/2026
Myriad Genetics USD 4.4M 600K Dec/2025
Otsuka Holdings JPY 8.54B 6.32B Sep/2026
Pfizer USD 662M 5M Sep/2026
United Therapeutics USD 2.9M 0 Sep/2026